IL10 and cancer: These compounds have the ability to block T cell activity, increase the production of immune suppressor molecules like transforming growth factor-β(TGF-β), vascular endothelial growth factor, and interleukin-10(IL-10), leading to the eventual spread of cancer cells (Figure 1) (14, 15).